期刊文献+

心力衰竭患者血浆可溶性晚期糖基化终末产物受体(sRAGE)变化与心功能的关系 被引量:11

Relationship between plasma sRAGE and heart function in patients with heart failure
下载PDF
导出
摘要 目的:探讨心力衰竭患者血浆可溶性晚期糖基化终末产物受体(soluble receptor for advanced glycation endproducts, RAGE)浓度变化,分析 sRAGE 与心功能的关系。方法选择首都医科大学附属北京同仁医院就诊的心力衰竭患者,纽约心脏学会(New York Heart Association,NYHA)心功能分级为Ⅱ~Ⅳ级,同期住院非心力衰竭患者为对照组,用酶联免疫吸附测定法方法定量检测血浆 sRAGE 浓度,对比分析各组间血浆 sRAGE 浓度的差异。结果血浆 sRAGE 浓度在对照组为(0.562±0.473)ng/mL,心力衰竭组为(0.844±0.705)ng/ mL,2组间比较差异有统计学意义(P〈0.01)。血浆 sRAGE 浓度在 NYHAⅡ级组为(0.680±0.506)ng/ mL、NYHAⅢ级组(0.844±0.646)ng/ mL、NYHAⅣ级组(91.077±0.910)ng/ mL。各组间比较差异有统计学意义(P〈0.05)。结论心力衰竭患者血浆 sRAGE 水平升高,且与心力衰竭的严重程度相关。 Objective To investigate the level of soluble receptor for advanced glycation endproducts(sRAGE) in patients with heart failure, to analyze the relationship between sRAGE and heart function. Methods Select 100 patients with heart failure treated in our hospital(NYHA Ⅱ-Ⅳ), at the same time collect 50 cases hospitalized without heart failure, record general condition, and use the ELISA method to detect the levels of plasma sRAGE, applied SPSS 16. 0 software to carry on statistical analysis. Results The plasma sRAGE level was increased in patients with heart failure than the control group, showing a significant difference(P〈0. 01). Plasma sRAGE level in the control group was(0. 562 ± 0. 473) ng/ mL, in the heart failure group was(0. 844 ± 0. 705) ng/ mL. With the cardiac function classification increased, plasma sRAGE level was elevated also, the control group was(0. 562±0. 473)ng/ mL, NYHAⅡ level group was (0. 680±0. 506)ng/ mL, NYHAⅢ level group was(0. 844 ±0. 646) ng/ mL, NYHAⅣ level was(1. 077 ±0. 910) ng/ mL. there is a significant difference ( P = 0. 004). The plasma level of sRAGE had negative correlation with LVEF in patients with heart failure. Conclusion The plasma level of sRAGE was elevated in patients with heart failure, the level of plasma sRAGE and severity degree of heart failure present a associated relationship, with NYHA heart function classification increased, the plasma sRAGE level was elevated too.
出处 《首都医科大学学报》 CAS 2014年第6期805-808,共4页 Journal of Capital Medical University
基金 国家自然科学基金(81370313) 北京市科技新星计划基金(2010B050)~~
关键词 心力衰竭 可溶性晚期糖基化终末产物受体 严重程度 heart failure soluble receptor for advanced glycation endproducts severity level
  • 相关文献

参考文献17

  • 1Bierhaus A,Humpert P M,Morcos M,et al.Understanding RAGE,the receptor for advanced glycation end products[J].J Mol Med,2005,83(11):876-886.
  • 2Sakurai S,Yamamoto Y,Tamei H,et al.Development of ELISA for sRAGE and its application to type 1 diabetic patients[J].Diabetes Res Clin Pract,2006,73(2):158-165.
  • 3Raucci A,Cugusi S,Antonelli A,et al.A soluble form of the receptor for advanced glycation end products(RAGE)is produced by proteolytic cleavage of the membrane bound form by the sheddase a disintegrin and metalloprotease 10(ADAM10)[J].FASEB J,2008,22(10):3716-3727.
  • 4Basta G,Sironi A M,Lazzerini G,et al.Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein[J].J Clin Endocrinol Metab,2006,91(11):4628-4634.
  • 5邵亚辉,许顶立.糖基化终极产物对心血管系统的损伤作用及干预措施[J].中国分子心脏病学杂志,2004,4(4):253-256. 被引量:7
  • 6Petrova R,Yamamoto Y,Muraki K,et al.Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes[J].J Mol Cell Cardiol,2002,34(10):1425-1431.
  • 7Raposeiras-Roubín S,Rodio-Janeiro B K,GrigorianShamagian L,et al.Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score[J].Am J Cardiol,2011,107(6):938-944.
  • 8Polyakova V,Hein s,Kostin S,et al.Matrixmetalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression[J].J Am Coil Cardiol,2004,44(8):1609-1618.
  • 9Mahajan N,Dhawan V.Receptor for advanced glycation end products(RAGE)in vascular and inflammatory diseases[J].Int J Cardiol,2013,168(3):1788-1794.
  • 10Devangelio E,Santilli F,Formoso G,et al.Soluble RAGE in type 2 diabetes:association with oxidative stress[J].Free Radic Biol Med,2007,43(4):511-518.

二级参考文献34

  • 1郭军,鲍翠玉,林国生,杨波.新生大鼠心肌细胞培养方法的改进[J].心血管康复医学杂志,2006,15(6):538-540. 被引量:13
  • 2Desai K,Wu L. Methylglyoxal and advanced glycation endproducts: new therapeutic horizons [J ]. Recent Pat Cardiovasc Drug Discov, 2007,2(2) : 89-99.
  • 3Mcnulty M, Mahmud A, Feely J. Advanced glycation end-products and arterial stiffness in hypertension [J]. Am J Hypertens,2007,20 ( 3 ) : 242-247.
  • 4Kakuta H, Sudoh K, Sasamata M, et al. Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor:comparison with other angiotensin IItype 1 receptor blockers [J]. Int Clin Pharmacol Res, 2005,25( 1 ) :41-46.
  • 5Yamamoto K, Ohishi M, Ho C, et al.Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-aetivated receptor-gamma activation[J]. Hypertension, 2009,54(6) : 1353-1359.
  • 6Yamagishi S, Matsui T, Nakamura K, et al. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-γ activation[J]. Protein Pept Lett, 2008, 15(8):850-853.
  • 7Vasdev S,Gill V,Sinqal P,et al. Role of advanced glycation end products in hypertension and atherosclerosis:therapeutic implication [ J ]. Cell Biochem Biophy, 2007,49( 1 ) : 48-63.
  • 8Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature [J]. Circ Res,2010,106(5) : 842-853.
  • 9Wei Y,Whaley-Connell AT,Chen K,et al. NADPH oxidasecontributes to vascular inflammation, insulin resistance, and re-modeling in the transgenic (mRen2) rat[J]. Hypertension,2007,50(6) : 384-391.
  • 10Zhao Z Q, Corvera J A, Halkos M E, et al. Inhibition of myocardial injury by ischemic postconditioning during reper- fusion : comparison with ischemic preconditioning [ J ]. Am J Physiol Heart Circ Physia|, 2003,285 (2) : H579 - 588.

共引文献17

同被引文献88

引证文献11

二级引证文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部